We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Noninvasive Methods Detect Lead Exposure Faster, Easier and More Accurately at POC

By LabMedica International staff writers
Posted on 30 Oct 2024

Exposure to lead can negatively affect health in multiple ways, leading to damage in the brain and central nervous system, delays in development and growth, learning and behavioral issues, problems with hearing and speech, reproductive health complications, kidney damage, high blood pressure, anemia, and more. More...

The standard method for measuring lead exposure is through a blood test, which only reflects exposure from the past 30 days. If this test is conducted outside that timeframe—especially in children—clinicians may not receive results that accurately represent chronic cumulative exposure in the body. Additionally, measuring bone lead levels is crucial because lead, which mimics calcium upon entering the body, disrupts pathways to the brain and accumulates in the bone. However, older technologies used to assess bone lead exposure have several limitations, including their size, the need for specialized knowledge, reliance on rare elements, and slow processing times. Now, researchers have developed noninvasive methods that can detect lead exposure levels in both bone and blood more quickly, easily, and sensitively at the point of care compared to traditional techniques.

The innovative, patent-pending technology developed by researchers at Purdue University (West Lafayette, IN, USA) utilizes portable X-ray fluorescence (XRF) analyzers to measure lead exposure in bone and blood. This new approach with portable XRFs addresses the limitations associated with traditional bone testing. The XRF analyzer employs a straightforward ‘point-and-shoot’ process, and results are available on the analyzer's tablet within minutes. Training an individual to operate this system takes only about 30 minutes, enabling them to perform measurements that can identify community-level lead exposure. The next step for the research team involves securing support from health leaders to incorporate this technology into national cohort studies and routine surveillance, which could help establish national standards for cumulative lead exposure.

Additionally, researchers have developed a method for detecting lead levels in dried blood spots, which is a significant improvement over the traditional approach that requires venous blood draws sent to a laboratory for analysis. The new technique allows for lead detection using dried blood spots, which can be collected much more easily with just a finger prick, requiring only a small amount of capillary blood. As long as more than 10 microliters of blood is present on the dried spot, the test can provide an accurate lead measurement. Similar to the bone test technology, this innovation enhances accessibility for underserved communities and rural populations and offers better sensitivity than existing tests. Both advancements have potential applications for health officials globally. The research on these methods has been published in the September 2024 issue of Current Environmental Health Reports and the March 2021 issue of Environmental Science & Technology.

“It can be difficult to assess their lead exposure levels because it’s hard to get them to a centralized clinic, unlike in an urban environment where people visit a clinic often. By using a portable XRF analyzer, health officials can travel to a community, conduct testing, quickly receive results and move on to the next community,” said Aaron Specht, assistant professor in the School of Health Sciences, who has developed both the technologies. “Our new method detects lead using dried blood spots, which are much easier to collect; they require just a finger prick and only a very small volume of capillary blood. As long as there’s more than 10 microliters of blood on that dried blood spot, we will have an accurate measurement of lead.”


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Collection and Transport System
PurSafe Plus®
Clinical Chemistry System
P780
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.